At a glance
- Originator Nonindustrial source
- Class Antibacterials
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pneumocystis pneumonia
Most Recent Events
- 17 Jun 2001 No-Development-Reported for Pneumocystis pneumonia in USA (Unknown route)
- 08 Apr 1998 New profile
- 08 Apr 1998 Preclinical development for Pneumocystis pneumonia in USA (Unknown route)